Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by PeterMacd2on Oct 03, 2019 2:02pm
105 Views
Post# 30192768

RE:RE:why is aphria

RE:RE:why is aphriaDon't blame Irwin Simon for the present state of the share price.  He doesn't control what happens to other comanies, and they've come down about the same percentages as APHA has since Jan 2019.  No, I think you can squarely lay this at the feet of the mysterious "market makers".  No-one really knows who they are, or whether they've conspired to bring APHA and the whole industry down.  (But  I think it's very suspicious; at least we can say it's inexplicable).

Consider this:  at today's SP, APHA has a total value (Supposedly) of $1.7 billion. That's all!   So all of the assets including physical property - the land (including foreign holdings), buildings, standing crop of plants already in the greenhouses - plus the company's intellectual property including developed cultivars and custom automation, plus the existing revenue stream which turned a net profit some months ago --- that's worth only $1.7 billion? Really?  APHA net sales last quarter were - what - about CAD$130 Million. Even IF revenue stays flat in the next 3 quarters that's still $0.5 billion revenue per year, for a supposedly $1.7 billion company. How realistic is that?  So not only is the present SP not counting in any future revenue increase, it is not even reflecting the current revenues plus assets. CC Pharma alone does ~ 200 million Euros of business a year, and its been consistent for many years https://www.cc-pharma.com.  And Broken Coast is already a star in APHA's stable. So something is very very out of whack with the market cap, and MM manipulation is the only logical answer to me. Sometime, however, the sheer illogicallity of this situation will have to collapse, the market will eventually have to revert APHA to its logical value, because that's what the market always does in the end. The sheer amount of money this company is making now argues for a SP something like 2 to 5 times higher than now (depending on what valuation factor you want to use). So stay long and reflect on what APHA has, and is, and will be.



Bullboard Posts